Named on 9 rounds in the feed, most often at Series B and in Biotech.
Rounds from 2017-08-10 to 2026-09-23
ROUNDS
9
led 1, joined 8
LED ROUNDS · USD
$37.5M
across 1 round · 1 co-led, split evenly
CO-INVESTORS
47
most often with Andreessen Horowitz
Named on 9 rounds in the feed, most often at Series B and in Biotech.
Rounds from 2017-08-10 to 2026-09-23
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
BigHat Biosciences A clinical-stage, AI-driven protein therapeutics platform company | Series C Verified against 4 of 28 sources | $75M | 2026-09-23 | [ PART ] |
Network Bio Network Bio develops AI models to interpret human health data for disease detection and personalized therapies. | Funding round Verified against 1 of 7 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $50M | 2026-08-19 | [ PART ] |
BigHat Biosciences A clinical-stage, AI-driven protein therapeutics platform company | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $75M | 2022-07-20 | [ LEAD ] |
Cohere Cohere builds powerful models and AI solutions enabling enterprises to automate processes, empower employees, and turn fragmented data into actionable insights. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $125M | 2022-02-16 | [ PART ] |
Cohere Cohere builds powerful models and AI solutions enabling enterprises to automate processes, empower employees, and turn fragmented data into actionable insights. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $40M | 2021-09-07 | [ PART ] |
Aspen Neuroscience Aspen Neuroscience develops personalized regenerative therapies, specifically autologous iPSC-derived cell replacement therapies for Parkinson's disease. | Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $70M | 2020-04-01 | [ PART ] |
Aspen Neuroscience Aspen Neuroscience develops personalized regenerative therapies, specifically autologous iPSC-derived cell replacement therapies for Parkinson's disease. | Seed Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $6.5M | ~ 2019-12-12 | [ PART ] |
Lime Lime sells electric scooters and bikes for urban transportation to consumers. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2017-10-16 | [ PART ] |
Coinbase Coinbase is a secure online platform for buying, selling, transferring, and storing cryptocurrency. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2017-08-10 | [ PART ] |